Part,  Chapter, Paragraph

 1   II,     5.  2.  6|        randomised trials of statins. Lancet 366: 1267-1278.~Lewington
 2   II,     5.  2.  6|              61 prospective studies. Lancet 360: 1903-1913.~Kannel WB (
 3   II,     5.  2.  6|              55,000 vascular deaths. Lancet 370: 1829-1839.~Robinson
 4   II,     5.  2.  6|      overviews of randomised trials. Lancet 362: 1527-1535.~Vasan RS,
 5   II,     5.  2.  7|          MONICA Project populations. Lancet 335:675-87.~Palmieri L,
 6   II,     5.  2.  7|              cardiovascular disease. Lancet 353:1547-57.~Tunstall-Pedoe
 7   II,     5.  2.  7|          MONICA Project populations. Lancet 355:688-700~Uemura K, Pisa
 8   II,     5.  2.  7|          study): case-control study. Lancet 364: 937-952.~ ~ ~
 9   II,     5.  3.  9|             of the EUROCARE-4 study. Lancet Oncology 8 (9):773-783.~ ~
10   II,     5.  3.  9|         analysis of EUROCARE-4 data. Lancet Oncology 8 (9): 784-796.~ ~
11   II,     5.  4.  3|             in the Nordic countries (Lancet, 2000). These data allowed
12   II,     5.  4.  8|        childhood diabetes in Europe. Lancet 11;355 873-6~EUDIP group (
13   II,     5.  5.  2|          Delphi consensus study. The Lancet, Vol. 366, December 17/24/
14   II,     5.  5.  3|       randomised clinical trial. The Lancet 371: 1085-1097.~Klosterkötter
15   II,     5.  5.  3|        health without mental health. Lancet 370(9590):859-77.~Punnoose
16   II,     5.  5.  3|            Stigma and mental health. Lancet 370(9590):810-11.~Sato M (
17   II,     5.  5.  3| classification: a prospective study. Lancet Neurol 4:627-634.~Osservatorio
18   II,     5.  5.  3|         wake-up call for management. Lancet 359:1790-1791.~Rutter M,
19   II,     5.  5.  3|              and multiple sclerosis. Lancet 7;268-277.~Ekestern E, Lebhart
20   II,     5.  6.  6|            of chronic low-back pain. Lancet 354:581-585~Andersson HI,
21   II,     5.  6.  6|              an observational study. Lancet 353:878-882~Combe B, Landewe
22   II,     5.  7.  7|            in chronic renal failure. Lancet 2000 Jul 8;356(9224):147-
23   II,     5.  8.  7|    population-base prevalence study. Lancet; 370: 741-750.~ ~Calverley
24   II,     5.  8.  7|              inflammatory syndrome?. Lancet 2007; 370: 797-799.~ ~Fabbri
25   II,     5.  8.  7|              population health data. Lancet 2006; 367: 1747-1757.~ ~
26   II,     5.  8.  7|       prevalence, and future trends. Lancet 370: 765-773.~ ~Masa JF,
27   II,     5.  8.  7|             Burden of Disease Study. Lancet 349: 1498–1504.~ ~Murtagh
28   II,     5. 12.  7|            in Britain, 1950 to 2002. Lancet 367:645.~ ~National Cancer
29   II,     5. 12.  7|              2008): Liver Cirrhosis. Lancet 371: 83851~ ~Shapiro CN,
30   II,     5. 12.  7|         hepatitis C virus infection. Lancet Infect Dis 5:558-567.~ ~
31   II,     5. 14.  8|            NB (2007): Dental caries. Lancet 2007; 369: 5159.~Wid A (
32   II,     9.  1.  1|           centres: a database study. Lancet 2007;369(9555):43-50.~Prysak
33   II,     9.  1.  2|          Food with Folic Acid?", The Lancet, Vol 369, pp 641-642.~Bianchi
34   II,     9.  1.  2|      Research Council Vitamin Study. Lancet 338: 131-7.~Schaefer C,
35   II,     9.  3.  1|             Million Women Study. The Lancet; 362; 9382; 419-427.~ ~Boyle,
36   II,     9.  3.  1|             of EUROCARE-4 data." The Lancet Oncology 8(9): 784-796.~ ~
37   II,     9.  3.  2|           centres: a database study. Lancet 2007;369(9555):43-50.~ ~
38   II,     9.  3.  3|             and HIV risk behaviours. Lancet 358:1835-42.~Kangas I, Andersen
39   II,     9.  3.  3|        pregnancy, hormones, and HIV. Lancet 366:1141-42.~Nikula M, Kaponen
40   II,     9.  3.  3|             heterosexual experience. Lancet 358(9296): 1843-1850.~Wellings
41   II,     9.  3.  3|       context: a global perspective. Lancet Series: Sexual and Reproductive
42   II,     9.  3.  3|          teenage pregnancy strategy: Lancet 368:1846-1848~ ~ ~
43   II,     9.  5.  6|             the Million Women Study. Lancet 362 419427.~ ~Bonté J (
44  III,    10.  1.  3|          regional burden of disease. Lancet 2002; 360: 1347-60.~Fagard
45  III,    10.  2.  1|          retrospective cohort study. Lancet, 2007; 369: 2015-20Martinet
46  III,    10.  2.  1|            disease burden in adults. Lancet, 2006; 367: 749-53.~ ~WHO (
47  III,    10.  2.  1|           crisis, common sense cure. Lancet 360:473-482.~ ~European
48  III,    10.  2.  4|           the InterLymph Consortium. Lancet Oncol, 7(1):27-38.~ ~Schulte
49  III,    10.  3.  2|             of industrial chemicals. Lancet 368, 2167-2178.~ ~Westfälisches
50  III,    10.  5.  1|          intervention study. In: The Lancet. 2002 Oct 19;360(9341):1184-
51  III,    10.  5.  1|           and the built environment. Lancet 29;370(9593): 1175-87~ ~
52  III,    10.  5.  3|             increasing unemployment. Lancet, 208-213.~ ~Schumpeter J (
53   IV,    11.  6.  5|   reflections on WHO's methods." The Lancet 361: 1817-20.~ ~Navarro
54   IV,    11.  6.  5|           World Health Report 2000." Lancet 356: 1598-1601.~ ~Naylor
55   IV,    11.  6.  5|         late-modern medicalisation.” Lancet 369: 698-700~ ~Vagac L,
56   IV,    13.  9    |          regional burden of disease. Lancet 2002; 360: 1347-60.~Fazi